Additionally, CDC25A and CAK, which sustain CDK2 activation, are upregulated in a range of tumors, particularly in breast cancer.306,307 Cyclin E overexpression is a driving event in high-grade serous ovarian cancer (HGSOC) and define a subgroup of HGSOC constitutively resistant to platinum-based chemotherapy. This evidence concerns the gene CDK7 and breast cancer.